Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms

NCT: NCT07316088 · ACTIVE_NOT_RECRUITING

NCT IDNCT07316088
StatusACTIVE_NOT_RECRUITING
Start Date2025-12-09
Completion2026-08-17
SponsorOui Therapeutics, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑